According to Orchard Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ4.93. In 2022 the company made an earnings per share (EPS) of -ยฃ9.38 a decrease over its 2021 EPS that were of -ยฃ9.38.